Skip to main content

Table 1 PK parameters of DB-1310 (5 mg/kg, i.v.) in the NCI-H441 model

From: DB-1310, an ADC comprised of a novel anti-HER3 antibody conjugated to a DNA topoisomerase I inhibitor, is highly effective for the treatment of HER3-positive solid tumors

Tissue

Analyte

Tmax

t1/2

Cmax

AUC0 − t

h

h

ng/mL

ng.h/mL

Serum

ADC

0.0830

119

90,996

4,355,036

Total antibody

0.0830

118

79,688

3,766,065

P1021

4.00

144

0.318

29.8

Tumor

ADC

48.0

88.4

5021

558,242

Total antibody

48.0

87.8

4544

500,316

P1021

24.0

59.9

6.27

424